Missag H. Parseghian

1.2k total citations
29 papers, 990 citations indexed

About

Missag H. Parseghian is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Missag H. Parseghian has authored 29 papers receiving a total of 990 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Immunology. Recurrent topics in Missag H. Parseghian's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Glycosylation and Glycoproteins Research (5 papers) and Genomics and Chromatin Dynamics (5 papers). Missag H. Parseghian is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Glycosylation and Glycoproteins Research (5 papers) and Genomics and Chromatin Dynamics (5 papers). Missag H. Parseghian collaborates with scholars based in United States, Canada and Switzerland. Missag H. Parseghian's co-authors include Barbara A. Hamkalo, Keith A. Luhrs, Xu Lu, Jeffrey C. Hansen, Robert Newcomb, Eli Y. Adashi, Shaorong Gao, Keith E. Latham, Young Gie Chung and Gretchen King and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Journal of the American College of Cardiology.

In The Last Decade

Missag H. Parseghian

29 papers receiving 929 citations

Peers

Countries citing papers authored by Missag H. Parseghian

Since Specialization

Citations

This map shows the geographic impact of Missag H. Parseghian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Missag H. Parseghian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Missag H. Parseghian more than expected).

Fields of papers citing papers by Missag H. Parseghian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Missag H. Parseghian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Missag H. Parseghian. The network helps show where Missag H. Parseghian may publish in the future.

Co-authorship network of co-authors of Missag H. Parseghian

This figure shows the co-authorship network connecting the top 25 collaborators of Missag H. Parseghian. A scholar is included among the top collaborators of Missag H. Parseghian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Missag H. Parseghian. Missag H. Parseghian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phosgene: toxicology, animal models, and medical countermeasures 2021 ·Toxicology Mechanisms and Methods ·Stephen T. Hobson, (unknown), Missag H. Parseghian	23
2	Cardioprotective Effects of HSP72 Administration on Ischemia-Reperfusion Injury 2017 ·Journal of the American College of Cardiology ·Takashi Tanimoto, Missag H. Parseghian, Takehiro Nakahara, Hideki Kawai, Navneet Narula, Dong‐Bin Kim, Robert N. Nishimura, Richard H. Weisbart, Grace Chan, (unknown), Nezam Haider, Farhan Chaudhry, (unknown), John Billimek, Francis G. Blankenberg, Partho P. Sengupta, Artiom Petrov, Takashi Akasaka, H. William Strausś, Jagat Narula	35
3	What is the role of histone H1 heterogeneity? A functional model emerges from a 50 year mystery 2015 ·SHILAP Revista de lepidopterología ·Missag H. Parseghian, (unknown)	24
4	High efficacy vasopermeability drug candidates identified by screening in an ex ovo chorioallantoic membrane model 2015 ·Scientific Reports ·Desmond Pink, Keith A. Luhrs, Longen Zhou, (unknown), J. Chase, (unknown), (unknown), (unknown), (unknown), John D. Lewis, Andries Zijlstra, Missag H. Parseghian	7
5	Application of monoclonal antibodies for the diagnostic and therapeutic targeting of human tumors with a necrotic component 2014 ·Russian Journal of General Chemistry ·Missag H. Parseghian, Eugene Mechetner, (unknown), (unknown)	1
6	Real-Time Visualization and Quantitation of Vascular Permeability In Vivo: Implications for Drug Delivery 2012 ·PLoS ONE ·Desmond Pink, (unknown), Missag H. Parseghian, Andries Zijlstra, John D. Lewis	37
7	The effects of hitchhiker antigens co-eluting with affinity-purified research antibodies 2011 ·Journal of Chromatography B ·(unknown), (unknown), (unknown), Pete Gagnon, Missag H. Parseghian	16
8	Clinical Update: Treatment of Glioblastoma Multiforme with Radiolabeled Antibodies that Target Tumor Necrosis 2010 ·Current Cancer Therapy Reviews ·Randy L. Jensen, Joseph Shan, (unknown), (unknown), Steven King, Jennifer C. Lai, Missag H. Parseghian	2
9	Evicting hitchhiker antigens from purified antibodies 2009 ·Journal of Chromatography B ·Keith A. Luhrs, (unknown), (unknown), Missag H. Parseghian	27
10	In-Line Radiolabeling: A Novel Continuous-Flow System for Commercial-Scale Protein Labeling 2009 ·Journal of Nuclear Medicine ·(unknown), (unknown), (unknown), (unknown), Robert Waibel, P. August Schubiger, Steven W. King, Missag H. Parseghian	2
11	Chromatin Condensing Functions of the Linker Histone C-Terminal Domain Are Mediated by Specific Amino Acid Composition and Intrinsic Protein Disorder 2008 ·Biochemistry ·Xu Lu, Barbara A. Hamkalo, Missag H. Parseghian, Jeffrey C. Hansen	83
12	Toxicity and biodistribution of an iodine‐131‐radiolabelled tumour necrosis‐targeting antibody in non‐tumour‐bearing domestic felines 2006 ·Veterinary and Comparative Oncology ·(unknown), Missag H. Parseghian	4
13	Rapid H1 linker histone transitions following fertilization or somatic cell nuclear transfer: evidence for a uniform developmental program in mice 2003 ·Developmental Biology ·Shaorong Gao, Young Gie Chung, Missag H. Parseghian, Gretchen King, Eli Y. Adashi, Keith E. Latham	110
14	Distribution of somatic H1 subtypes is non‐random on active vs. inactive chromatin II: Distribution in human adult fibroblasts 2001 ·Journal of Cellular Biochemistry ·Missag H. Parseghian, Robert Newcomb, Barbara A. Hamkalo	38
15	A compendium of the histone H1 family of somatic subtypes: An elusive cast of characters and their characteristics 2001 ·Biochemistry and Cell Biology ·Missag H. Parseghian, Barbara A. Hamkalo	11
16	Identification of Histone H1 as a Cognate Antigen of the Ulcerative Colitis-associated Marker Antibody pANCA 2000 ·Journal of Autoimmunity ·Mark Eggena, Offer Cohavy, Missag H. Parseghian, Barbara A. Hamkalo, D. P. Clemens, Stephan R. Targan, Lynn K. Gordon, Jonathan Braun	61
17	The distribution of somatic H1 subtypes is non-random on active vs. inactive chromatin: Distribution in human fetal fibroblasts 2000 ·Chromosome Research ·Missag H. Parseghian, Robert Newcomb, Sara T. Winokur, Barbara A. Hamkalo	63
18	A proposal for a coherent mammalian histone H1 nomenclature correlated with amino acid sequences 1994 ·Protein Science ·Missag H. Parseghian, Agnes Henschen, (unknown), Barbara A. Hamkalo	65
19	Characterization of a set of antibodies specific for three human histone H1 subtypes 1994 ·Chromosoma ·Missag H. Parseghian, (unknown), (unknown), Barbara A. Hamkalo	30
20	Fractionation of human H1 subtypes and characterization of a subtype-specific antibody exhibiting non-uniform nuclear staining 1993 ·Chromosome Research ·Missag H. Parseghian, Robert Clark, Loren Hauser, (unknown), (unknown), Barbara A. Hamkalo	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact